Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

Technology Scientific & Technical Instruments
MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Medx Health Corp > Proper Research on MedX
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(92)
•••
Post by Insightful1on Feb 28, 2021 12:24pm
280 Views
Post# 32681556

Proper Research on MedX

Proper Research on MedX

I think Bob McWhirter was an early stage investor in MedX back at the .$10 range, he annonced he only held warrants ( One of his BNN interviews) which means when the stock got ahead of itself back in 2018 he must have sold his position. 

The most knowledgable analyst that follows MedX is Doug Cooper at Beacon Securities. Doug always updates his coverage when MedX makes a material announcement. MedX has Institutional Investors now who trust Doug's guidance and that would explain the volume and higher prices. Note in the latest report MedX is still deeply undervalued on a comparative basis.

Here is Doug's report;

https://medxhealth.com/assets/research/MDX-2020-12-15.pdf
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities